Tumor volume dynamics and tumor growth rate in ALK-rearranged advanced non-small-cell lung cancer treated with crizotinib

Tumor volume dynamics and tumor growth rate in ALK-rearranged advanced non-small-cell lung cancer treated with crizotinib

Purpose: The purpose of the study is to investigate volumetric tumor burden dynamics and tumor growth rates in ALK-rearranged advanced NSCLC patients during crizotinib monotherapy. Methods: The study included 44 ALK-rearranged advanced NSCLC patients treated with crizotinib monotherapy as their init...

Full description

Bibliographic Details
Main Authors: Mizuki Nishino, Tomoyuki Hida, Sasha Kravets, Suzanne E. Dahlberg, Christine A. Lydon, Hiroto Hatabu, Bruce E. Johnson, Mark M. Awad
Format: Article
Language:English
Published: Elsevier 2020-01-01
Series:European Journal of Radiology Open
Subjects:
Lung cancer
Non-small cell
ALK rearrangement
Crizotinib
Tumor growth rate
Precision therapy
Online Access:http://www.sciencedirect.com/science/article/pii/S2352047719300516

Internet

http://www.sciencedirect.com/science/article/pii/S2352047719300516

Similar Items